{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:31:16Z","timestamp":1789669876616,"version":"4.0.1"},"reference-count":107,"publisher":"The Korean Association for the Study of the Liver","issue":"1","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["e-cmh.org"],"crossmark-restriction":true},"short-container-title":["Clin Mol Hepatol"],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:p>Hepatitis B virus (HBV) affects approximately 250 million patients worldwide, resulting in the progression to cirrhosis and hepatocellular carcinoma, which are serious public health problems. Although universal vaccination programs exist, they are only prophylactic and not curative. In the HBV life cycle, HBV forms covalently closed circular DNA (cccDNA), which is the viral minichromosome, in the nuclei of human hepatocytes and makes it difficult to achieve a complete cure with the current nucleos(t)ide analogs and interferon therapies. Current antiviral therapies rarely eliminate cccDNA; therefore, lifelong antiviral treatment is necessary. Recent trials for antiviral treatment of chronic hepatitis B have been focused on establishing a functional cure, defined by either the loss of hepatitis B surface antigen, undetectable serum HBV DNA levels, and\/or seroconversion to hepatitis B surface antibody. Novel therapeutic targets and molecules are in the pipeline for early clinical trials aiming to cure HBV infection. The ideal strategy for achieving a long-lasting functional or complete cure might be using combination therapies targeting different steps of the HBV life cycle and immunomodulators. This review summarizes the current knowledge about novel treatments and combination treatments for a complete HBV cure.<\/jats:p>","DOI":"10.3350\/cmh.2021.0093","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T07:37:18Z","timestamp":1626766638000},"page":"17-30","update-policy":"https:\/\/doi.org\/10.3350\/crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus"],"prefix":"10.3350","volume":"28","author":[{"given":"Sun Woong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Sik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4488-5352","authenticated-orcid":true,"given":"Yuri","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1902","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i21.2261"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401771101"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7554\/elife.00049"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00873-12"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01207-09"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-016-0432-7"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13175"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.08.002"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.11.015"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2014.02.002"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i1.48"},{"key":"ref12","first-page":"370","volume-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","year":"2017"},{"key":"ref13","first-page":"93","volume-title":"KASL clinical practice guidelines for management of chronic hepatitis B","year":"2019"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa051285"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0802878"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23327"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3486-7"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.018"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243462"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.5279"},{"key":"ref22","first-page":"555","volume-title":"Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon alpha2a (40 kda; PEGASYS)","author":"Chan","year":"2008"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-010-9208-0"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26180"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06576.x"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12990"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320015"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/cej.0000000000000428"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01902-09"},{"key":"ref30","first-page":"81","volume-title":"Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in combination with PEG-interferon Alpha 2a in patients with chronic HBV\/HDV co-infection","author":"Wedemeyer","year":"2019"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.12.008"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26982"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/s0618-8278(19)30916-8"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7554\/elife.26738"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308964"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23778"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.31867"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2016.08.004"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2016.07.001"},{"key":"ref40","first-page":"1454A1455A","volume-title":"Safety, pharmacokinetics and anti-viral efficacy of novel core protein allosteric modifier GLS4 in patients with chronic hepatitis B: interim results from a 48 weeks phase 2a study","author":"Zhang","year":"2018"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.023"},{"key":"ref42","first-page":"490A","volume-title":"Single dose safety, tolerability, and pharmacokinetics of AB-423 in healthy volunteers from the ongoing single and multiple ascending dose study AB-423-001","author":"Eley","year":"2017"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/s0618-8278(19)30925-9"},{"key":"ref44","first-page":"47A","volume-title":"Safety, pharmacokinetics and antiviral activity of a novel hepatitis B virus (HBV) capsid assembly modulator, JNJ56136379, in patients with chronic hepatitis B (CHB)","author":"Zoulim","year":"2018"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/s0618-8278(19)30230-0"},{"key":"ref46","first-page":"e491","volume-title":"RO7049389, a core protein allosteric modulator, demonstrates robust decline in HBV DNA and HBV RNA in chronic HBV infected patients","author":"Yuen","year":"2019"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025096"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8844061"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10200-5"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305138"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.11.001"},{"key":"ref52","first-page":"243","volume-title":"Randomised clinical trial: safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection","author":"Zhang","year":"2021"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00794-10"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/genes9040207"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1126\/science.1231143"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.20"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.170"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.05.010"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.94"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/srep10833"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00091"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/srep13734"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(17)31855-x"},{"key":"ref64","volume-title":"Characterization of a KDM5 small molecule inhibitor with antiviral activity in rodent livers","author":"Gilmore"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56842-9"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.019"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1172\/jci58847"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.07.004"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.02.058"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth854"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31008"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(20)30597-3"},{"key":"ref73","first-page":"433A","volume-title":"Results after 12 weeks treatment of multiple doses of GSK3389404 in chronic hepatitis B subjects on stable nucleos(t)ide therapy in a phase 2a double-blind, placebo-controlled study","author":"Yuen","year":"2019"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.026"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.5009\/gnl17233"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.42"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1159\/000090001"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.10.027"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31255"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(20)30650-4"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.016"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/s0618-8278(19)30084-2"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(20)30766-2"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.028"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23936"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24249"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(99)70188-5"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(01)00028-9"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.09.072"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.274"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305707"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2013.65"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12530"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.027"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308041"},{"key":"ref96","first-page":"215","volume-title":"Hepatitis B: current status of therapy and future therapies","author":"Spyrou","year":"2020"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.10.025"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.04.047"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa040431"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa043470"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)17701-0"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.09.043"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa807"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01477-8"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(20)30646-2"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309809"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.008"}],"container-title":["Clinical and Molecular Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2021-0093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2021.0093","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2021-0093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T05:14:50Z","timestamp":1641791690000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2021.0093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"URL":"https:\/\/doi.org\/10.3350\/cmh.2021.0093","relation":{},"ISSN":["2287-2728","2287-285X"],"issn-type":[{"value":"2287-2728","type":"print"},{"value":"2287-285X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]},"assertion":[{"value":"2021-03-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-20","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}